About Us
Overview
Leadership
Directors & Advisors
Corporate Social Responsibility
Services
Microbiome LBP Manufacturing
Process & Formulation Development
Analytical Development & QC
Clinical + Commercial Manufacturing
mRNA Vaccine Manufacturing
Process Development & Characterization
Analytical Development & QC
Clinical + Commercial Manufacturing
Custom Biomanufacturing Solutions
Facilities
Careers
Working at Arranta
Training & Benefits
Internships
Browse Opportunites & Apply
Contact Us
Menu
Menu
News
Resources
Request More Information
News
Filter by:
Select
Events
News
Press Release
Press Release
December 14, 2020
Arranta Bio Announces Pledge to Diversity, Inclusion and Sustainability with CSR Program
Read More
Press Release
December 4, 2020
Arranta Bio Named Finalist for Gainesville Chamber Life Science Company of the Year
Read More
News
November 18, 2020
Arranta Bio Named Honoree in GrowFL Companies to Watch
Read More
Press Release
September 28, 2020
Arranta Bio Announces Mechanical Completion of Commercial-Ready Capacity for advanced biologics
Read More
Press Release
June 15, 2020
Arranta Bio Announces Addition of Shailesh Maingi to its Board as an Independent Director
Read More
Press Release
May 29, 2020
Arranta Bio Announces Completion of its Microbiome Process Development Lab Expansion and Commitment to Additional Early Clinical GMP Capacity
Read More
News
April 2, 2020
Aaron Cowley Talks Process Development of LBPs
Read More
Press Release
January 30, 2020
Arranta Bio announces key leadership additions of Chief Operations Officer and SVP of Business Development as it commits to a $100M investment in building end-to-end microbiome capacity
Read More
Press Release
November 13, 2019
Arranta Bio announces the acquisition of Captozyme™, creating a Center of Excellence for microbiome development and clinical supply
Read More
‹
1
2
3
›
